Skip to content
Disclosery

PharVision Advisers, LLC: UGP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on UGP, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 20,690 UGP shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 20,690 shares
    Change vs previous 13F +6,167 shares

    1.96% of the 13F portfolio, value $103,864.

    13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 14,523 shares
    Change vs previous 13F -37,357 shares

    0.81% of the 13F portfolio, value $80,022.

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 51,880 shares
    Change vs previous 13F +23,498 shares

    0.1% of the 13F portfolio, value $195,588.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 28,382 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $116,366.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).